Return
to: U of M Home
|
  |
|
|
|
||
 |
Mechanical Engineering Home > Seminars > Spring 2004 Seminars |
ME/IE 8773-8774
Main Department Seminar
Host: Joachim V.R. Heberlein Novel Medical Aerosols for Global Health by David A. Edwards Wednesday, January 28, 2004 Abstract: Since their publication in 1997, large porous particle (LPP) aerosols have been developed to deliver drugs to the lungs for improved standard therapies for asthma, COPD, and other respiratory illnesses, as well as to pioneer new inhalation therapies for systemic delivery of proteins such as insulin and growth hormone. This talk will review the basic science, commercial translation and clinical development of LPP aerosols and discuss how these and other new aerosol particle designs can be used through nonprofit and for-profit entities to treat problems of global health, like tuberculosis. Bio: David A. Edwards is the Gordon McKay Professor of the Practice of Biomedical Engineering in DEAS at Harvard. A member of the National Academy of Engineering, he is a pioneer of novel medical aerosols for the treatment of pulmonary and systemic diseases. He has authored or co-authored 70 research publications, two textbooks in the area of applied mathematics, and over 25 patents or patent applications. David is the cofounder of Advanced Inhalation Research, now part of Alkermes, Inc., Medicine in Need (or MEND), a not-for-profit dedicated toward the development of more effective treatments of tuberculosis in nations of poverty, and Pulmatrix, which explores novel methods for slowing the spread of inhaled infectious diseases. His research and teaching at Harvard continue in the vein of medical aerosols, with a current focus on nanoparticle delivery systems. Informal Faculty Luncheon: Wednesday, January 28, 2004, 12:00 noon. Meet in 1100 ME and walk to lunch with other faculty. Prof. Edwards will be able to attend. |
|
||||
|